Loading...
SUN Pharmaceutical Industries Limited — Calcium Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Calcium · $57.0M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Calcium with $57.0M in export value and 1,558 verified shipments. SUN Pharmaceutical Industries Limited holds a 6.4% market share in Calcium exports across 22 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $24.2M | 1,061 | 59.7% |
| AUSTRALIA | $5.6M | 259 | 13.9% |
| SOUTH AFRICA | $2.9M | 144 | 7.3% |
| MYANMAR | $2.3M | 55 | 5.6% |
| SRI LANKA | $1.6M | 41 | 4.0% |
| CANADA | $1.0M | 31 | 2.5% |
| OMAN | $924.4K | 36 | 2.3% |
| MAURITIUS | $640.8K | 22 | 1.6% |
| QATAR | $208.9K | 13 | 0.5% |
| BRAZIL | $196.9K | 20 | 0.5% |
SUN Pharmaceutical Industries Limited exports Calcium to 22 countries. The largest destination is BELGIUM accounting for 59.7% of SUN Pharmaceutical Industries Limited's Calcium shipments, followed by AUSTRALIA (13.9%) and SOUTH AFRICA (7.3%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $23.3M | 1,033 |
| SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $2.4M | 98 |
| SUN PHARMA ANZ PTY LTD. | AUSTRALIA | $2.0M | 119 |
| RANBAXY PHARMACEUTICALS PTY LTD., | SOUTH AFRICA | $1.3M | 75 |
| MYIT MAHAR TRADING CO., LTD. | MYANMAR | $1.1M | 24 |
| SUN PHARMA ANZ PTY LTD | AUSTRALIA |
India exported $222.8M worth of Calcium through 15,000 shipments from 996 suppliers to 184 countries, serving 2,554 buyers globally. SUN Pharmaceutical Industries Limited contributes $57.0M to this total, accounting for 6.4% of India's Calcium exports. SUN Pharmaceutical Industries Limited ships Calcium to 22 countries through 105 buyers.
SUN Pharmaceutical Industries Limited's average Calcium shipment value is $36.6K per consignment, based on 1,558 shipments totaling $57.0M. The largest destination is BELGIUM (59.7% of SUN Pharmaceutical Industries Limited's Calcium exports).
SUN Pharmaceutical Industries Limited ranks #4 among 996 Indian Calcium exporters with a 6.4% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($57.0M), BIOCON PHARMA LIMITED ($43.3M), GRAVITI PHARMACEUTICALS PRIVATE LIMITED ($25.0M). SUN Pharmaceutical Industries Limited processed 1,558 shipments to 22 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ATORVASTATIN CALCIUM TABLETS 20MG ( ATOR | $1.0M | 48 |
| ATORVASTATIN CALCIUM TABLETS 20MG ( ATORVASTATIN SUN FC TAB 20MG ) EACH FILM-COATED TABLET CONTAINS: ATORVASTATIN CALCIU | $949.0K | 77 |
| ATORVASTATIN CALCIUM TABLETS 40MG ( ATOR | $878.7K | 35 |
| ROSUVASTATIN CALCIUM TABLETS 10MG ( ROSU | $688.2K | 20 |
| ATORVASTATIN CALCIUM TABLETS 80MG ( ATOR | $597.1K | 13 |
| ATORVASTATIN CALCIUM TABLETS 10MG ( ATOR | $579.1K | 25 |
| ATORVASTATIN CALCIUM TABLETS 40MG ( ATORVASTATIN SUN FC TAB 40MG ) EACH FILM-COATED TABLET CONTAINS: ATORVASTATIN CALCIU | $483.4K | 16 |
| ROSUVASTATIN CALCIUM TABLETS 10MG ( ROSUVASTATINE SUN 10MG FC TAB ) EACH FILM-COATED TABLET CONTAINS: ROSUVASTATIN CALCI |
What SUN Pharmaceutical Industries Limited must comply with to export Calcium to its top destination countries
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $57.0M | 1,558 | 22 | $36.6K |
| 5 | BIOCON PHARMA LIMITED | $43.3M | 865 | 4 | $50.0K |
| 7 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $25.0M | 713 | 1 | $35.0K |
SUN Pharmaceutical Industries Limited ranks #4 among 996 Indian Calcium exporters. Average shipment value of $36.6K compared to the market average of $223.7K. The closest competitors by value are BIOCON PHARMA LIMITED and GRAVITI PHARMACEUTICALS PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,737 | 11.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,272 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 991 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 865 | 5.8% |
| DELHI AIR | 787 | 5.2% |
| HYDERABAD ICD | 640 | 4.3% |
| DELHI AIR CARGO ACC (INDEL4) | 559 | 3.7% |
| JNPT | 542 | 3.6% |
SUN Pharmaceutical Industries Limited also exports these vitamins & supplements products. Each links to the detailed product page.
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Calcium, top products include Strip, Esomeprazole, Magnesium, Omeprazole, Atorvastatin. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Calcium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Calcium exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
| $599.1K |
| 21 |
| RANBAXY PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $541.8K | 24 |
| RANBAXY PHARMACEUTICALS PTY LTD | SOUTH AFRICA | $513.9K | 14 |
| SUN PHARMA CANADA INC | CANADA | $408.4K | 12 |
| MYIT MAHAR TRADING CO. LIMITED | MYANMAR | $392.7K | 9 |
SUN Pharmaceutical Industries Limited supplies Calcium to 105 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN PHARMA ANZ PTY LIMITED (AUSTRALIA) and SUN PHARMA ANZ PTY LTD. (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $473.7K |
| 14 |
| ATORVASTATIN SZ 80MG EACH FILM COATED TABLET CONTAINS:ATORVASTATIN CALCIUM EQ TOATORVASTATIN 80 MG PACK : BOX3X10S | $429.6K | 12 |
| ROSUVASTATIN CALCIUM TABLETS 5MG ( ROSUV | $402.0K | 14 |
SUN Pharmaceutical Industries Limited exports 832 distinct Calcium formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN CALCIUM TABLETS 20MG ( ATOR with 48 shipments worth $1.0M.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 184+ countries, 2,554+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Calcium. For current shipment-level data, contact TransData Nexus.